FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
36 letters match. Newest first.
-
DrugsTSP Solutions Pte. Ltd.
FDA warns Singapore OTC drug maker TSP Solutions over missing release testing and component identity checks for sunscreens.
High risk -
FoodAmerican Pharma Mfg. Inc.
FDA warns American Pharma Mfg. of serious dietary supplement manufacturing violations at its Ontario, CA facility.
High risk -
DrugsHappy Farm Botanicals, Inc.
Happy Farm Botanicals, an OTC drug maker in Hyattsville, MD, cited for skipping ingredient identity tests and stability testing, repeat violations.
High risk -
FoodMeta Labs Pharmaceuticals, LLC
FDA warns Meta Labs its supplements are unapproved drugs and have serious manufacturing violations.
High risk -
DrugsRespilon Production S.R.O.
FDA found Respilon, a Czech OTC drug maker, lacked ingredient identity testing, stability data and process validation.
Medium -
DrugsLexia LLC
FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.
High risk -
DrugsYangzhou H&R Plastic Daily Chemical Co., Ltd.
Yangzhou H&R Plastic Daily Chemical, a Chinese contract manufacturer, lacked release testing and CGMP controls for its OTC drug.
High risk -
DrugsCosmetic Manufacturers Pty Ltd.
FDA warned Cosmetic Manufacturers Pty Ltd. that its Australian drug site was adulterated due to CGMP violations and placed its drugs on import alert.
High risk -
FoodCC Pollen Company
FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.
High risk -
DrugsABBE Laboratories, Inc.
FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.
High risk -
DrugsGussyup LLC dba Private Label Grooming
FDA found Gussyup LLC, a Henderson, Nevada OTC drug maker, lacking quality oversight and ingredient identity testing; company stopped drug production.
High risk -
DrugsZhejiang Easyclean Daily Chemical Co., Ltd
FDA warned Zhejiang Easyclean Daily Chemical that its OTC drugs lacked required testing and manufacturing controls.
High risk -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
DrugsPMS4PMS, LLC
FDA warns PMS4PMS of Clarence, NY, over CGMP failures and an unapproved menstrual cramp relief cream.
High risk -
DrugsMarshalls Traditional Healthcare CC
Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.
High risk -
DrugsCatwalk Cosmetic Laboratories Pty Ltd.
FDA warns South African over-the-counter drug maker Catwalk Cosmetic Laboratories of current good manufacturing practice violations and import alert.
High risk -
DrugsOriginitalia SRL
FDA warns Originitalia SRL over manufacturing quality failures in OTC drugs, including untested active ingredient and missing release testing.
High risk -
DrugsEnviroServe Chemicals & Cleaners Ltd.
EnviroServe's SOPURE hand sanitizer had manufacturing-quality violations and was sold as an unapproved, misleadingly labeled drug.
High risk -
DrugsAvaria Health & Beauty Corp.
FDA warns Canadian maker Avaria Health & Beauty over CGMP failures in OTC drug products, including skipped ingredient identity testing.
High risk -
DrugsLS Promotions Inc.
LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.
High risk -
FoodWest Coast Laboratories, Inc.
FDA warned West Coast Laboratories over dietary supplements made without required manufacturing controls and illegally labeled.
High risk -
DrugsYangZhou SuXiang Medical Instrument Co., Ltd.
FDA warns YangZhou SuXiang Medical Instrument over manufacturing quality failures and import alert for OTC drugs.
High risk -
DrugsSeatex, LLC
FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.
High risk -
DrugsJiangsu Meifan Biotechnology Co. Ltd.
FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.
High risk -
DrugsBodywell Natural Skin Care Inc.
FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.
High risk -
DrugsThai Nakorn Patana Co., Ltd.
FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.
High risk -
DrugsCerci Kozmetik Ve Otel Ekipmanlari Pazarlama Ic Ve Dis Ticaret Limited Sirketi
FDA: Turkish OTC drug maker Cerci shipped to the U.S. without finished-product identity and strength testing.
High risk -
FoodBrand Packaging Group, Inc.
Brand Packaging Group, a Farmingdale, NY dietary supplement maker, failed to test finished batches and ingredient identity, FDA found.
High risk -
FoodSpartan Enterprises Inc. dba Watershed Wellness Center
FDA warned Spartan Enterprises/Watershed Wellness that its Dr. Bob’s Naturals supplements are unapproved drugs and are made under CGMP violations.
High risk -
DrugsFormology Lab Inc.
FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.
High risk -
FoodAmerican Chinese Natural Herbs, Inc.
FDA warned Garland, Texas-based American Chinese Natural Herbs, Inc. about adulterated (legally unsafe) dietary supplements made without required manufacturing controls and with mislabeled products.
High risk -
DrugsSanitizer Supply LLC
FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.
High risk -
FoodMuscle Feast, LLC
Muscle Feast, LLC lacked ingredient identity and finished-product specifications for dietary supplements, FDA says.
Medium -
FoodMCACO, LTD
FDA cited MCACO for manufacturing-quality violations in its dietary supplements.
Medium -
DrugsGulsah Uretim Kozmetik Sanayi Anonim Sirketi
Turkish OTC drug maker Gulsah failed to test its products and ingredients, and FDA blocked its U.S. imports.
High risk -
DrugsNatural Beauty Care Pty Ltd
FDA warned Natural Beauty Care Pty Ltd that its OTC drugs are adulterated due to CGMP failures and no finished-product or ingredient testing.
High risk